The changes in the rat parotid glands following total parenteral nutrition and pancreatico-biliary diversion are not mediated by cholecystokinin

International Journal of Pancreatology

Volumn 20, Issue 2, 1996, Pages 109-118

  Axelson, Jan ^a   Fan, Bo Guang ^a   Ohlsson, Bodil ^a   Rehfeld, Jens ^b   Ekelund, Mats ^a   Ihse, Ingemar ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Rigshospitalet   (Denmark)

Author keywords

Cholecystokinin (CCK); devazepide; pancreas; pancreatico biliary diversion (PBD); parotid glands; total parenteral nutrition (TPN); trophic effects

Indexed keywords

CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ OCTAPEPTIDE; DEVAZEPIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA CONTENT; DOSE TIME EFFECT RELATION; MALE; NONHUMAN; PANCREAS SURGERY; PAROTID GLAND; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TOTAL PARENTERAL NUTRITION;

AMYLASES; ANIMALS; BENZODIAZEPINONES; BILE DUCTS; CHOLECYSTOKININ; DEVAZEPIDE; DNA; HORMONE ANTAGONISTS; MALE; ORGAN SIZE; PANCREAS; PANCREATIC DUCTS; PARENTERAL NUTRITION, TOTAL; PAROTID GLAND; RATS; RATS, SPRAGUE-DAWLEY; SINCALIDE;

EID: 10544244578     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Young JA, Cook DI, van Lennep EW, Roberts M. Secretion of the major salivary glands, in Physiology of the Gastrointestinal Tract, vol. 7, Johnson LR, ed., Raven, New York, 1987: pp. 73-815.
2. Skude G, Ihse I. Salivary amylase in duodenal aspirates. Scand J Gastroenterol 1976; 11: 17-20.
3. Lankisch PG, Otto J. Salivary isoamylase in duodenal aspirates. Dig Dis Sci 1986; 31: 1299-1302.
4. Axelson J, Hakanson R, Ihse I, Lilja I, JRehfeld JF, Sundler F. Effects of endogenous cholecystokinin and of infusion with the cholecystokinin antagonist L-364,718 on pancreatic and gastrointestinal growth. Scand J Gastroenterol 1990; 25: 471-480.
5. Saikatsu S, Ikeno K, Hanada Y, Ikeno T. Intravenous injection of cerulein or cholecystokinin increases the parotid-type amylase in the serurn of rats. Shika Kiso Igakkai Zasshi 1989; 31: 592-596.
6. Grimmel K, Rossbach G, Kasper H. Amylase activity of parotid saliva in acute and chronic pancreatitis. Acta Hepatogastroenterol 1976; 23: 334-344.
7. Hirano T, Manabe T, Tobe T. Cellular alterations of parotid gland of rats with acute pancreatitis induced by cerulein. Int J Pancreatol 1991; 10: 217-227.
8. Miazza BM, Turberg Y, Guillaume P, Hahne W, Chayvialle JA, Loizeau E. Mechanism of pancreatic growth induced by pancreatico-biliary diversion in the rat. Scand J Gastroenterol 1985; 20: 75-83.
9. Fölsch UR, Cantor P, Wilms HM, Schafmayer A, Becker HD, Creutzfeldt W. Role of cholecystokinin in the negative feedback control of pancreatic enzyme secretion in conscious rats. Gastroenterology 1987; 92: 449-458.
10. Hughes CA, Breuer RS, Ducker DA, Hatoff DE, Dowling RH. The effect of cholecystokinin and secretin on intestinal and pancreatic structure and function, in Mechanisms of Intestinal Adaptation, Robinson JWL, Dowling RH, Riecken EO, eds., MTP, Lancaster, 1981: pp. 435-450.
11. Miazza BM, van Hung L, Vaja S, Dowling RH. Pancreatic hyperplasia after pancreatico biliary diversion (PBD) in orally and parenterally fed rats, in Mechanisms of Intestinal Adaptation, Robinson JWL, Dowling RH, Riecken EO, eds., MTP, Lancaster, 1981: pp. 481-490.
12. Nylander AG, Chen D, Ihse I, Rehfeld JF, Håkanson R. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide. Scand J Gastroenterol 1992; 27: 743-747.
13. Solomon TE, Yamada T, Elashoff J, Wood J, Beglinger C. Bioactivity of cholecystokinin analogues: CCK-8 is not more potent than CCK-33. Am J Physiol 1984; 253: 4016-4021.
14. Ohlsson B, Axelson J, Sternby B, Rehfeld JF, Ihse I. Time course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor. Int J Pancreatol 1995; 18: 59-66.
15. Rehfeld JF. Immunochemical studies on cholecystokinin. I. Development of sequence-specific radioimmunoassays for porcine triacontratriapeptide cholecystokinin. J Biol Chem 1978; 253: 4016-4021.
16. Cantor P. Evaluation of a radioimmunoassay for cholecystokinin in human plasma. Scand J Lab Invest 1986; 46: 213-221.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
18. Dahlqvist A. A method for the determination of amylase in intestinal content. Scand J Clin Lab Invest 1962; 14: 145-151.
19. Nagy I, Pap A, Varró V. Time-course of changes in pancreatic size and enzyme composition in rats during starvation. Int J Pancreatol 1989; 5: 35-45.
20. Iovanna JL, Dusetti NJ, Cadenas MB, Mallmann MC, Calco EL. Changes in pancreatic trophism and gene expression during a prolonged fasting period in rats. Int J Pancreatol 1991; 8: 177-186.
21. Koop I, Kimmich T, Koop H, Arnold R. Effect of food deprivation on the function of intestinal cholecystokinin-producing cell in the rat. Digestion 1987; 38: 114-123.
22. Nealon WH, Upp JR, Jr., Alexander RW, Gomez G, Townsend CM, Thompson JC. Intravenous amino acids induce human gallbladder contraction. Am J Physiol 1990; 259: G173-G178.
23. Adler G, Beglinger C, Braun U, Reinshagen M, Koop I, Schafmayer A, Rovati L, Arnold R. Interaction of the cholinergic system and cholecystokinin in the regulation of endogenous and exogenous stimulation of pancreatic secretion in humans. Gastroenterology 1991; 100: 537-543.
24. Schneyer CA, Hall HD. Amylase and electrolyte changes after postganglionic parasympathectomy of parotid gland. Am J Physiol 1964; 207: 308-312.
25. Jaworek J, Konturek SJ, Bielanski W, Bilski J, Hladij M. Release and binding of epidermal growth factor in the pancreas of rats. Int J Pancreatol 1992; 11: 19-17.
26. Ino M, Ushiro K, Ino C, Yamashita T, Kumazawa T. Kinetics of epidermal growth factor in saliva. Acta Otolaryngol Suppl Stockh 1993; 500: 126-130.
27. Dembinski A, Gregory H, Konturek SJ, Polanski M. Trophic action of epidermal growth factor on the pancreas and gastrointestinal mucosa in rats. J Physiol 1982; 325: 35-42.
28. Ohlsson B, Jansen C, Ihse I, Axelson J. Epidermal growth factor induces cell proliferation in mouse pancreas and salivary glands. Pancreas 1996, in press.
29. Gasslander T, Chu M, Smeds S, Ihse I. Proliferative response of different exocrine pancreatic cells following surgical pancreatico-biliary diversion. Scand J Gastroenterol 1991; 26: 399-404.
30. Chu M, Borch K, Lilja I, Blomqvist, Rehfeld JF, Ihse I. Endogenous hypercholecystokininemia model in the hamster: trophic effect on the exocrine pancreas. Pancreas 1992; 7: 220-225.
31. Gasslander T, Axelson J, Håkanson R, Ihse I, Lilja I, Rehfeld JF. Cholecystokinin is responsible for growth of the pancreas following pancreatico-biliary diversion in rats. Scand J Gastroenterol 1990; 25: 1060-1065.
32. Schick J, Kern H, Scheele G. Hormonal stimulation in the exocrine pancreas results in coordinate and anticoordinate regulation of proteinsynthesis. J Cell Biol 1984;99: 1569-1574.
33. Fölsch UR, Winckler K, Wormsley KG. Influence of repeated administration of cholecystokinin and secretin on the pancreas of the rat. Scand J Gastroenterol 1978; 13: 663-671.